Drug
W0180
W0180: highest development phase Phase 1, developed by Pierre Fabre. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Pierre Fabre
Trials
| Drug | Phase | Indication |
|---|---|---|
| W0180 NCT04564417 | Phase 1 | Locally Advanced or Metastatic Solid Tumors |
Latest
No recent events.
Follow W0180 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.